Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
Dean Celia
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care
News
PhRMA Maps Provide State-by-State Look at 340B Drug Program
04/05/2024
Paul Nicolaus
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024

Danielle Sposato

Danielle Sposato
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care

Advertisement

News
Medicare Drug Price Negotiations and Anticipated Ripple Effects
02/15/2024
Paul Nicolaus
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
Population Health

Advertisement

News
Low Rate of Social Determinants of Health Z Codes in Adults With Hypertension
06/26/2023
Jolynn Tumolo
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the...
06/26/2023
First Report Managed Care
News
CDC Data Shows Link Between High Costs and Prescription Nonadherence in Adults
06/21/2023
Julie Gould
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence...
06/21/2023
First Report Managed Care
News
Blood Pressure Injections Recalled
05/26/2023
Jolynn Tumolo
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network

Advertisement

News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
Jolynn Tumolo
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

What's Trending?

Department
Optimal Response to Natalizumab in MS Patients
06/19/2012

Eileen Koutnik-FotopoulosÔªø

Eileen Koutnik-FotopoulosÔªø
Results from a small study found that inhibition of intrathecal antibody synthesis is associated with a complete therapeutic response to natalizumab in patients with aggressive multiple sclerosis (MS). Treatment with natalizumab decreased the...
Results from a small study found that inhibition of intrathecal antibody synthesis is associated with a complete therapeutic response to natalizumab in patients with aggressive multiple sclerosis (MS). Treatment with natalizumab decreased the...
Results from a small study found...
06/19/2012
First Report Managed Care
News
IV Opioid Solution Recalled
12/27/2016
The US Food and Drug Administration has recalled a strong opioid used to manage severe pain after sterility problems were made evident to the manufacturer. 
The US Food and Drug Administration has recalled a strong opioid used to manage severe pain after sterility problems were made evident to the manufacturer. 
The US Food and Drug...
12/27/2016
Pharmacy Learning Network
News
Antibiotic Development May Not be Bad Business for Drugmakers
12/26/2013
Drug companies have tapered the development of new antibacterials amid uncertainty about their profit potential, but a look at the history of these drugs shows they sell well in most cases, researchers say.
Drug companies have tapered the development of new antibacterials amid uncertainty about their profit potential, but a look at the history of these drugs shows they sell well in most cases, researchers say.
Drug companies have tapered the...
12/26/2013
Pharmacy Learning Network
Troubles With Drug Pricing Transparency
07/18/2019

Mary Beth Nierengarten

Mary Beth Nierengarten
Experts discuss the complications of drug pricing transparency, focusing on the rule requiring drug manufacturers to disclose list prices in TV advertisements, which has since been blocked by a federal judge.
Experts discuss the complications of drug pricing transparency, focusing on the rule requiring drug manufacturers to disclose list prices in TV advertisements, which has since been blocked by a federal judge.
Experts discuss the...
07/18/2019
First Report Managed Care
News
Horizon Blue Cross Must Turn Over Data on Narrow Network Plans
04/12/2018
A New Jersey judge ruled that Horizon Blue Cross Blue Shield must make a consulting report that led to the development of its narrow network OMNIA plans available to the public.
A New Jersey judge ruled that Horizon Blue Cross Blue Shield must make a consulting report that led to the development of its narrow network OMNIA plans available to the public.
A New Jersey judge ruled that...
04/12/2018
First Report Managed Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use